Bryan Davis
Pain Medicine · Boston, MANPI 1205361276
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,498 of the $3,654 with a category attached, or 68.4%. Medtronic accounts for 64.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,386 and has fallen 84.5% since, to $214 in 2025.
Across 51 payments — averaging $71.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- AbbVie$44
- Saluda Medical Americas, Inc.$39
- Globus Medical$34
- Avanos Medical$31
- plus $38 from 2 others
What the payments were for
- Travel & lodging$2,49868%
- Food & beverage$1,15632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 30 | $2,341 |
| Boston Scientific | 12 | $1,126 |
| AbbVie | 2 | $44 |
| Saluda Medical Americas, Inc. | 2 | $39 |
| Globus Medical | 1 | $34 |
| Avanos Medical | 2 | $31 |
| Abbott | 1 | $29 |
| GRT US Holding, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,654 in reported general payments places this provider in the 60th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 21 | $4,803 |
| Duloxetine Hcl | 50 | $1,110 |
| Gabapentin | 72 | $876 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $653 |
| Pregabalin | 30 | $260 |
| Nortriptyline Hcl | 29 | $227 |
| Baclofen | 11 | $159 |
| Methocarbamol | 16 | $152 |
| Celecoxib | 17 | $130 |
| Meloxicam | 28 | $90 |
| Amitriptyline Hcl | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Boston
- Thomas SimopoulosBoston$181K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Eduard VaynbergBoston$32K
- David HaoBoston$16K
- Erika YihBoston$8K
- Samuel AngBoston$7K
- Kevin VuBoston$6K
- Brenda LeeBoston$6K
- Steven MachBoston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.